Literature DB >> 25355806

Toll-like receptor 3 activation drives the inflammatory response in oxygen-induced retinopathy in rats.

Min Cai1, Xuedong Zhang1, Yingyuan Li1, Haiyan Xu1.   

Abstract

AIMS: Ischaemia is one of the most important causes of blindness. The purpose of this study was to investigate the potential role and mechanisms by which toll-like receptor 3 (TLR3) influences the progression of the inflammatory response in a rat model of oxygen-induced retinopathy (OIR).
METHODS: OIR rat models were successfully established and received single intravitreal injections of polyinosine-polycytidylic acid (poly (I:C)) and anti-TLR3 antibody, respectively, on postnatal day 17 (P17). Pathological retinal neovascularisation was evaluated by haematoxylin and eosin staining and immunohistochemistry with Isolectin B4 FITC (fluorescein isothyocyanate). Retinal expressions of TLR3 and nuclear factor kappa B (NF-κB) were measured using real-time PCR, immunohistochemistry and western blot. Furthermore, interleukin-6 (IL-6) and tumour necrosis factor α (TNFα) expression levels were assessed with real-time PCR and ELISA.
RESULTS: Both gene and protein expression levels of TLR3 and NF-κB were significantly elevated in the retinas of OIR rats compared to the controls. Increased IL-6 and TNFα expression levels were also observed in the retinas of OIR rats. Furthermore, TLR3 signalling pathway components, including NF-κB and IL-6/TNFα, were markedly upregulated upon stimulation with poly(I:C). In addition, the pre-treatment of TLR3 neutralising antibody in OIR models significantly decreased TLR3 and NF-κB expressions, as well as related inflammatory factors IL-6/TNFα expression.
CONCLUSIONS: Our results suggest that upregulation of the TLR3 signalling pathway is involved in the pro-inflammatory response in OIR rat retinas. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Experimental &#8211 animal models; Inflammation; Retina

Mesh:

Substances:

Year:  2014        PMID: 25355806     DOI: 10.1136/bjophthalmol-2014-305690

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

Review 1.  The role of Toll-like receptors in retinal ischemic diseases.

Authors:  Wen-Qin Xu; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 2.  Association between diabetic retinopathy and polymorphisms of cytokine genes: a systematic review and meta-analysis.

Authors:  Faria Jafarzadeh; Amin Javanbakht; Niloofar Bakhtar; Alaleh Dalvand; Mahya Shabani; Mohammad-Mehdi Mehrabinejad
Journal:  Int Ophthalmol       Date:  2021-08-25       Impact factor: 2.031

3.  NLRP3 Blockade Suppresses Pro-Inflammatory and Pro-Angiogenic Cytokine Secretion in Diabetic Retinopathy.

Authors:  Guangrui Chai; Shu Liu; Hongwei Yang; Guoqiang Du; Xiaolong Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-25       Impact factor: 3.168

4.  Thioredoxin-1 Ameliorates Oxygen-Induced Retinopathy in Newborn Mice through Modulation of Proinflammatory and Angiogenic Factors.

Authors:  Junichi Ozawa; Kosuke Tanaka; Yukio Arai; Mitsuhiro Haga; Naoyuki Miyahara; Ai Miyamoto; Eri Nishimura; Fumihiko Namba
Journal:  Antioxidants (Basel)       Date:  2022-04-30

5.  Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident Microglia.

Authors:  Lulu Yan; Sangmi Lee; Douglas R Lazzaro; Jacob Aranda; Maria B Grant; Brahim Chaqour
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

6.  Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model.

Authors:  Marina Renner; Gesa Stute; Mohammad Alzureiqi; Jacqueline Reinhard; Susanne Wiemann; Heiko Schmid; Andreas Faissner; H Burkhard Dick; Stephanie C Joachim
Journal:  Front Cell Neurosci       Date:  2017-08-22       Impact factor: 5.505

Review 7.  Role of Inflammation in Diabetic Retinopathy.

Authors:  Anne Rübsam; Sonia Parikh; Patrice E Fort
Journal:  Int J Mol Sci       Date:  2018-03-22       Impact factor: 5.923

8.  Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model.

Authors:  Marina Palmhof; Stephanie Lohmann; Dustin Schulte; Gesa Stute; Natalie Wagner; H Burkhard Dick; Stephanie C Joachim
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

Review 9.  A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases.

Authors:  Ashley Stark; Christiane Dammann; Heber C Nielsen; MaryAnn V Volpe
Journal:  Front Pediatr       Date:  2018-06-13       Impact factor: 3.418

10.  Single-Cell Analysis of the Neonatal Immune System Across the Gestational Age Continuum.

Authors:  Laura S Peterson; Julien Hedou; Edward A Ganio; Ina A Stelzer; Dorien Feyaerts; Eliza Harbert; Yamini Adusumelli; Kazuo Ando; Eileen S Tsai; Amy S Tsai; Xiaoyuan Han; Megan Ringle; Pearl Houghteling; Jonathan D Reiss; David B Lewis; Virginia D Winn; Martin S Angst; Nima Aghaeepour; David K Stevenson; Brice Gaudilliere
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.